0000950170-22-018700.txt : 20220921 0000950170-22-018700.hdr.sgml : 20220921 20220921090320 ACCESSION NUMBER: 0000950170-22-018700 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220915 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220921 DATE AS OF CHANGE: 20220921 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioAtla, Inc. CENTRAL INDEX KEY: 0001826892 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851922320 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39787 FILM NUMBER: 221255092 BUSINESS ADDRESS: STREET 1: 11085 TORREYANA ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-558-0708 MAIL ADDRESS: STREET 1: 11085 TORREYANA ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 8-K 1 bcab-20220915.htm 8-K 8-K
false0001826892BioAtla, Inc.00018268922022-09-152022-09-15

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 15, 2022

 

 

BIOATLA, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39787

85-1922320

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

11085 Torreyana Road

 

San Diego, California

 

92121

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 858 558-0708

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.0001 par value per share

 

BCAB

 

NASDAQ Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e)

 

On September 15, 2022, the Compensation Committee of the Board of Directors of BioAtla, Inc. (the “Company”) adopted the BioAtla, Inc. Management Change of Control Severance Plan (the “Plan”).

 

Eric Sievers, M.D., the Company’s Chief Medical Officer, and Christian Vasquez, the Company’s Vice President of Finance, Controller and Secretary, are eligible to participate in the Plan. Our other named executive officers are ineligible to participate in the Plan because they have previously entered into individual severance agreements.

 

Participants under the Plan are eligible to receive the following payments and benefits in the event of a termination by the Company without Cause or a Resignation by the Participant with Good Reason, in each case, during the twelve month period following a Change of Control:

 

a lump sum payment equal to 0.75 times the sum of the participant’s base salary for Vice Presidents and 1.0 times the sum of the participant’s base salary for Senior Vice Presidents and above;
a prorated portion of the participant’s target bonus amount for the year of termination; and
full vesting of the participant’s outstanding equity awards (assuming target achievement of any applicable performance-based vesting criteria to the extent the performance period has not yet been completed).

 

Receipt of benefits under the Plan is conditioned upon the Participant’s execution of a general release of claims and compliance with certain restrictive covenants running in favor of the Company.

 

The foregoing summary is qualified in its entirety by reference to the Plan, a copy of which is attached hereto as Exhibit 10.1 and which is incorporated herein by reference. All capitalized terms used above and not otherwise defined shall have the meaning given to such terms in the Plan.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit

Number

 

Description

10.1

 

BioAtla, Inc. Management Change of Control Severance Plan

104

 

Cover Page Interactive Data File


 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

BioAtla, Inc.

 

 

 

 

Date:

September 21, 2022

By:

/s/ Jay M. Short

 

 

 

Jay M. Short
Chief Executive Officer

 


EX-10.1 2 bcab-ex10_1.htm EX-10.1 EX-10.1

 

BIOATLA, INC.
MANAGEMENT CHANGE OF CONTROL SEVERANCE PLAN
AND SUMMARY PLAN DESCRIPTION

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


BIOATLA, INC.
MANAGEMENT CHANGE OF CONTROL SEVERANCE PLAN
AND SUMMARY PLAN DESCRIPTION

BioAtla, Inc. (the “Company”), and all of its U.S. based wholly owned subsidiaries (collectively, the “Employer”) have established this BioAtla, Inc. Management Change of Control Severance Plan (the “Plan”) with the intention of providing severance payments and benefits to eligible employees in the event of certain qualifying terminations of employment in connection with a change of control of the Company. The circumstances under which an eligible employee is entitled to severance payments and benefits hereunder are described further below.

This Plan supersedes and replaces all previous separation pay under any other plan, agreement, policy or program sponsored by the Employer for the eligible employees described below.

1.
Effective Date.

The effective date of this Plan is September 15, 2022.

2.
Certain Definitions.

For purposes of this Plan:

 

(i)
Accrued Benefits” shall mean, as of the date of a Participant’s termination of Active Status with the Employer, (a) such Participant’s accrued but unpaid base salary compensation and, to the extent required by applicable law, paid time off, (b) any earned but unpaid bonus for the fiscal year immediately preceding the fiscal year during which the termination of Active Status occurs, (c) other benefits earned, and reimbursements, under any Employer-provided plans, policies, and arrangements for the period preceding the effective date of the termination of Active Status, each in accordance with the governing documents and policies of any such benefits, reimbursements, plans and arrangements, and (d) such other compensation or benefits from the Employer as may be required by law.

 

(ii)
Active Status” shall mean the absence of any interruption or termination of service as an Employee. Active Status shall not be considered interrupted in the case of sick leave, maternity leave, infant care leave, medical emergency leave, military leave, or any other leave of absence properly taken in accordance with the policies of the Company or any applicable Subsidiary thereof as may be in effect from time to time. Whenever a mandatory severance period applies under applicable law with respect to a termination of service as an Employee, Active Status shall be considered terminated upon such Employee’s receipt of notice of termination in whatever form prescribed by applicable law.
(iii)
Base Salary” shall mean the Participant’s annualized basic weekly rate of wages or salary as in effect as of immediately prior to the date of the Participant’s CIC Qualifying Termination (or, in the case of a Resignation for Good Reason due to a material reduction in the Participant’s base salary, as in effect prior to such reduction), as applicable, including any wages or salary that are voluntarily deferred by the

- 2 -

 

 


Participant under a salary reduction agreement and are not includable in the gross income of the Participant under Sections 125, 402(a)(8), or 402(h) of the Internal Revenue Code. “Base Salary” does not include the Participant’s other benefits, bonuses or overtime earnings.

 

(iv)
Board” shall mean the Board of Directors of the Company.

 

(v)
Cause” shall mean (a) the Participant’s conviction of, or entry of a plea of nolo contendere (or similar disposition) in respect of, any felony or crime involving moral turpitude, (b) the Participant’s engagement in disloyalty to the Employer including fraud, embezzlement, theft, misappropriation or proven dishonesty, (c) the Participant’s breach of any written confidentiality, non-competition, non- solicitation agreement, or material Employer policy, in each case, regardless of whether such act or omission is materially injurious to the Employer, (d) the Participant’s continued failure to substantially perform his or her duties, which failure the Participant fails to cure (other than any such failure resulting from incapacity due to physical or mental illness, disability or an extended leave of absence) within ten (10) days after a written demand for substantial performance is delivered to the Participant by the Employer, which demand describes in reasonable detail the manner in which the Employer believes that the Participant has not substantially performed his or her duties, or (e) the Participant’s willful engagement in conduct which is materially injurious to the Employer, monetarily or otherwise; provided that, no act, or failure to act, on the Participant’s part shall be deemed “willful” unless done, or omitted to be done, by the Participant in bad faith and without reasonable belief that his or her action or omission was in, or not opposed to, the best interests of the Employer.

 

(vi)
Change of Control” shall mean (a) the acquisition in one or more transactions (whether by purchase, merger, amalgamation or otherwise) by any “Person” (as such term is used for purposes of Section 13(d) or Section 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), but excluding, for this purpose, (i) the Company and the Subsidiaries, (ii) any employee benefit plan of the Company or any Subsidiary or (iii) an entity owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of shares of the Company) of “Beneficial Ownership” (within the meaning of Rule 13d-3 under the Exchange Act), of more than fifty percent (50%) of the combined voting power of the Company’s then outstanding voting securities (the “Voting Securities”); (b) a change in the composition of the Board such that the individuals who as of any date constitute the Board (the “Incumbent Board”) cease to constitute a majority of the Board at any time during the 24-month period immediately following such date; provided, however, that if the election, or nomination for election by the Company’s stockholders, of any new director was approved by a vote of at least a majority of the Incumbent Board, such new director shall be considered as a member of the Incumbent Board, and provided further that any reductions in the size of the Board that are instituted voluntarily by the Incumbent Board shall not constitute a Change of Control, and after any such reduction the “Incumbent Board” shall mean the Board as so reduced; or (c) the sale, directly or indirectly, of all or substantially all of the Company’s and its Subsidiaries’ assets (determined on a consolidated basis), other than to a Person described in clauses (a)(i), (a)(ii) or (a)(iii) of this paragraph.

- 3 -

 

 


Notwithstanding the foregoing, a restructuring, reorganization or similar or analogous event in which the stockholders of the Company immediately before such event have “Beneficial Ownership” (within the meaning of Rule 13d-3 under the Exchange Act) of the Company, or of the resulting entity, immediately after such event in substantially the same proportions as their ownership of shares of the Company immediately before such event shall not constitute a Change of Control. In addition, if required for compliance with Section 409A, in no event will a Change of Control be deemed to have occurred if such transaction is not also a “change in the ownership or effective control of” the Company or “a change in the ownership of a substantial portion of the assets of” the Company as determined under Treasury Regulation Section 1.409A-3(i)(5) (without regard to any alternative definition thereunder).

 

(vii)
Change of Control Protection Period” shall mean the period commencing on the date of consummation of a Change of Control and ending on the date that is twelve (12) months immediately following the consummation of a Change of Control.
(viii)
CIC Qualifying Termination” shall mean an “involuntary separation from service” within the meaning of Section 409A due to a termination of a Participant’s Active Status by the Employer without Cause or a Resignation for Good Reason, in each case, during the Change of Control Protection Period. For the avoidance of doubt, the termination of a Participant’s Active Status due to death or disability shall not constitute a CIC Qualifying Termination for purposes of this Plan.

 

(ix)
CIC Severance Multiple” shall mean the applicable multiple set forth on Exhibit A attached hereto, unless otherwise specified by the Committee with respect to a Participant.
(x)
CIC Severance Period” shall mean the applicable period set forth on Exhibit A attached hereto immediately following the date of the CIC Qualifying Termination, unless otherwise specified by the Committee with respect to a Participant.
(xi)
Code” shall mean the Internal Revenue Code of 1986, as amended.

 

(xii)
Committee” shall mean the Compensation Committee of the Board.

 

(xiii)
Conditions” means (a) the Participant has returned all Employer property in the Participant’s possession within ten (10) business days following the date of the Participant’s CIC Qualifying Termination, as applicable, (b) the Participant has executed a separation and release agreement in a form acceptable to the Company (the “Release”), which Release shall include a full and complete general release of all claims that the Participant may have against the Employer, its affiliates, and their respective officers and directors, return of property and continued cooperation covenants, and such other covenants and provisions as the Company determines in its sole discretion, (c) the Release has become effective no later than the 30th day after the date of the Participant’s CIC Qualifying Termination, as applicable, or such later date as may be required by applicable law, and (d) the Participant’s continued compliance with Section 8 herein

- 4 -

 

 


and any other confidentiality, non-solicitation, non-competition, invention assignment, or similar agreement by and between the Participant and the Employer.

 

(xiv)
Eligible Position” shall mean each position set forth on Exhibit A attached hereto.

 

(xv)
Employee” shall mean any person, including an officer, who is a common law employee of, receives remuneration for personal services to, is reflected on the official human resources database as an employee of, and is on the payroll of an Employer. A person is on the payroll if he or she is paid from or at the direction of the payroll department of an Employer. Persons providing services to the Company, or to any Subsidiary or affiliate thereof, pursuant to an agreement with a staff leasing organization, temporary workers engaged through or employed by temporary or leasing agencies, and workers who hold themselves out to the Company or a Subsidiary or affiliate thereof to which they are providing services as being independent contractors, or as being employed by or engaged through another company while providing the services, and persons covered by a collective bargaining agreement (unless the collective bargaining agreement applicable to the person specifically provides for participation in this Plan) are not Employees for purposes of this Plan and do not and cannot participate in this Plan, whether or not such persons are, or may be reclassified by the courts, the Internal Revenue Service, the U.S. Department of Labor, or other person or entity as, common law employees of the Company, or any Subsidiary or affiliate thereof, either solely or jointly with another person or entity.

 

(xvi)
Participation Agreement” shall mean a participation letter or agreement in substantially the form attached as Exhibit B hereto.

 

(xvii)
Potential Change of Control” shall mean the earliest to occur of (a) the execution of an agreement or letter of intent, the consummation of the transactions described in which would result in a Change of Control, (b) the approval by the Board of a transaction or series of transactions, the consummation of which would result in a Change of Control, or (c) the public announcement of a tender offer for the Company’s voting stock, the completion of which would result in a Change of Control.”

 

(xviii)
Potential Change of Control Period” shall mean the period commencing on the date of a Potential Change of Control and ending on the date immediately preceding the date of the earlier to occur of (i) consummation of a Change of Control or (ii) the abandonment of the transactions contemplated by the Potential Change of Control.

 

 

(xix)
Resignation (or Resign) for Good Reason” shall mean the Participant’s resignation from employment with the Company if any of the following actions are taken by the Company without the Participant’s prior written consent: (i) a material reduction in the Participant’s base salary, unless pursuant to a salary reduction program applicable generally to similarly situated employees of the Company; (ii) a material reduction in the Participant’s duties (including responsibilities and/or authorities), provided, however, that a change in job position (including a change in title) shall not be deemed a "material reduction" in and of itself unless the Participant’s new duties are materially reduced from the prior duties; or (iii) relocation of the Participant’s principal place of

- 5 -

 

 


employment to a place that increases the Participant’s one-way commute by more than thirty-five (35) miles as compared to the Participant’s then-current principal place of employment immediately prior to such relocation. In order for the Participant to resign for Good Reason, each of the following requirements must be met: (A) the Participant must provide written notice to the Company within thirty (30) calendar days after the first occurrence of the event giving rise to Good Reason setting forth the basis for the Participant’s resignation, (B) the Participant must allow the Company at least thirty (30) calendar days from receipt of such written notice to cure such event, (C) such event is not reasonably cured by the Company within such thirty (30) calendar day period (the "Cure Period"), and (D) the Participant must resign from all positions the Participant then hold with the Company not later than thirty (30) calendar days after the expiration of the Cure Period.

 

(xx)
Restrictive Period” shall mean the applicable CIC Severance Period.

 

(xxi)
Section 409A” shall mean Code Section 409A and the Treasury Regulations promulgated thereunder.

 

(xxii)
Subsidiary” shall mean any corporation, partnership, joint venture, company or other business entity of which 50% or more of the outstanding voting power is beneficially owned, directly or indirectly, by the Company.
(xxiii)
Target Bonus” means a Participant’s target bonus, if any, as in effect for the fiscal year in which the CIC Qualifying Termination occurs (assuming all applicable performance goals and all applicable conditions are 100% satisfied).
3.
Eligibility for Participation.

Each Employee who (i) is employed by the Employer in the United States in an Eligible Position, (ii) is offered a Participation Agreement by the Company, and (iii) signs and returns a Participation Agreement shall be eligible to participate in this Plan (each such individual, a “Participant”). Any Employee with an individual agreement providing for severance shall not be eligible to be a Participant, unless otherwise determined by the Committee. Each Participant under this Plan shall not be eligible to participate in any other severance or separation pay plan.

4.
Change of Control Severance Benefits.

If a Participant experiences a CIC Qualifying Termination, then, in addition to the Accrued Benefits, the Employer will provide to such Participant the following severance benefits, subject to the Participant satisfying the Conditions:

(i)
The Employer will pay the Participant severance pay equal to the CIC Severance Multiple, multiplied by the Participant’s Base Salary (the “CIC Cash Severance Payment”). The CIC Cash Severance Payment will be paid in a lump sum within 10 business days following the date the Release becomes irrevocable, less applicable tax withholdings.

- 6 -

 

 


(ii)
The Employer will pay the Participant an amount equal to a prorated portion of the Participant’s target bonus amount for the year of the CIC Qualifying Termination (the “Target Bonus Amount) that corresponds to the Participant’s service during such year (the “Prorata Bonus Payment”) which shall be calculated by multiplying (i) the Target Bonus Amount, by (ii) a fraction, the numerator of which is the number of days during such year that the Participant was employed by the Company and the denominator of which is three hundred and sixty-five (365). The Prorata Bonus Payment will be paid to the Participant, in the form of a lump sum payment within 10 business days following the date the Release becomes irrevocable, less applicable tax withholdings. For purposes of calculating the Target Bonus Amount for any such year, the Participant’s final base salary will be calculated prior to giving effect to any reduction in base salary that would give rise to the Participant’s right to resign for Good Reason.
(iii)
All of the Participant’s outstanding unvested equity awards shall immediately vest as of the date of the Participant’s CIC Qualifying Termination (assuming target achievement of any applicable performance-based vesting criteria to the extent the performance period has not yet been complete) and shall settle, if applicable, within sixty (60) days of such termination (or such earlier time provided in the applicable award agreement); provided that to the extent necessary to avoid adverse tax treatment under Section 409A with respect to any equity award subject to Section 409A, such equity award shall instead be settled on the settlement date(s) applicable to such equity award under the applicable award agreement (or such earlier date(s) as are in compliance with Section 409A).
5.
Separation Offset

The severance payments and benefits payable pursuant to Section 4 will be reduced and/or offset by any notice payments, wages, salary and/or paid days in lieu of notice the Participant is given or is required to be given by the Employer to satisfy its obligations under WARN or any similar state statute. Any reduction or offset shall be taken from the payments and benefits first due under this Plan without affecting the time and form of the remaining payments. The value of benefits paid on behalf of but not directly to the Participant will not be treated as an offset.

6.
Time and Form of Payment.

Any severance payments and benefits that become payable pursuant to this Plan shall be paid at such time and in such form as set forth in Section 4; provided, however, if the payment and benefits under this Plan replace or substitute payments and/or benefits under another arrangement that is subject to Section 409A, then the severance and benefits that become payable pursuant to this Plan shall be paid at such time and in such form as under such other arrangement to extent required to comply with Section 409A. In the event a Participant entitled to receive severance payments and benefits under this Plan dies before receiving those payments and benefits, those payments and benefits will be paid to the Participant’s estate upon the estate’s execution of a full release of all claims against the Employer and its affiliates.

No benefits will be paid under this Plan until the Participant satisfies the Conditions. All benefits under this Plan are subject to any required withholding and payroll taxes.

- 7 -

 

 


Receipt of severance payments and benefits under this Plan shall be in lieu of any other severance payments or benefits under any other plan, policy or program sponsored by the Employer.

7.
Section 409A

Notwithstanding anything else herein to the contrary, to the extent any severance payments or benefits provided under this Plan in connection with the Participant’s termination of Active Status constitute deferred compensation subject to Section 409A and the Participant is deemed at the time of such termination to be a “specified employee” under Section 409A, then such payment shall not be made or commence until the earlier of (i) the expiration of the six-month period measured from the Participant’s separation from service (within the meaning of Section 409A) and (ii) the date of the Participant’s death, provided that such deferral shall be effected only to the extent required to avoid adverse tax treatment to the Participant, including, without limitation, the additional tax for which the Participant would otherwise be liable under Code Section 409A(a)(1)(B) in the absence of such a deferral. Following such a deferral, the first payment of any severance payment or benefit hereunder will include a catch-up payment covering the amount that would have otherwise been paid hereunder during the period between the Participant’s date of separation from service and the first payment date, but for the application of this provision, and the balance of the payments and benefits (if any) will be payable in accordance with their original schedule. To the extent any payment under this Plan may be classified as a “short-term deferral” within the meaning of Section 409A, such payment shall be deemed a short-term deferral, even if it may also qualify for an exemption from Section 409A under another provision thereof. Payments pursuant to this Plan are intended to constitute separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations. To the extent that any provision of this Plan is ambiguous as to its compliance with Section 409A and Section 409A applies to such provision, the provision will be read in such a manner so that all payments hereunder comply with Section 409A. To the extent any expense reimbursement or the provision of any in-kind benefit under this Plan is determined to be subject to Section 409A, the amount of any such expenses eligible for reimbursement, or the provision of any in-kind benefit, in one calendar year shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year (except, in the case of medical reimbursement arrangement, for any lifetime or other aggregate limitation applicable to expenses), in no event shall any expenses be reimbursed after the last day of the calendar year following the calendar year in which the Participant incurred such expenses, and in no event shall any right to reimbursement or the provision of any in-kind benefit be subject to liquidation or exchange for another benefit. Notwithstanding anything to the contrary herein, in no event shall the timing of a Participant’s execution of a release pursuant to this Plan result, directly or indirectly, in such Participant designating the calendar year of any payment hereunder, and, to the extent required by Section 409A, if a payment hereunder that is subject to execution of a release could be made in more than one taxable year, payment shall be made in the later taxable year. Notwithstanding the foregoing, the Employer makes no representations that the payments and benefits provided under this Plan comply with Section 409A and in no event shall the Employer, any Employer affiliates, or their respective employees, officers, directors, agents and representatives (including, without limitation, legal counsel) be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by Participant on account of non-compliance with Section 409A.

 

- 8 -

 

 


8.
Termination or Return of Benefits. A Participant’s right to receive benefits under this Plan shall terminate immediately either (a) if the Company establishes (whether before or after the Participant’s termination of Active Status) that the Participant engaged in any behavior constituting Cause or (b) if the Participant engages in any of the following actions (to the extent prohibition of such actions is permissible under applicable law) without the prior written approval of the Plan Administrator:
(i)
at any time prior, willfully breaches a material provision of any confidentiality, invention assignment, or similar agreement by and between the Participant and Employer;
(ii)
at any time prior to or during the applicable Restrictive Period, either directly or indirectly, on the Participant’s own behalf or on behalf of any other person or entity, by or through any means including but not limited to social media: (x) solicits, invites, induces, causes, or encourages any director, officer, employee, agent, representative, consultant, or contractor of the Employer to alter or terminate his, her, or its employment, relationship, or affiliation with the Employer; (y) interferes or attempts to interfere with any aspect of the relationship between the Employer and any such director, officer, employee, agent, representative, consultant, or contractor; or (z) engages, hires, or employs, or causes to be engaged, hired, or employed, in any capacity whatsoever, any such director, officer, employee, agent, representative, consultant, or contractor;
(iii)
at any time during Participant’s employment with Employer, for any reason, on the Participant’s own behalf or on behalf of any other person or entity, by or through any means including but not limited to social media: solicits, invites, induces, causes or encourages any of the Employer’s then current clients, customers, suppliers, vendors, distributors, licensors, licensees or other third party (or any such person or entity whose business the Employer was then soliciting or attempting to solicit) to terminate or materially diminish their existing business relationship with the Employer or interferes in any other manner with any existing business relationship between the Employer and any then current client, customer, supplier, vendor, distributor, licensor, licensee or other third party (or any such person or entity whose business the Employer was then soliciting or attempting to solicit);
(iv)
at any time, directly or indirectly, through any means including but not limited to social media, makes any derogatory, disparaging or negative comments about the products, officers, directors, consultants or employees of the Employer or any joint venture partner of the Employer (other than providing information to any governmental agency to the extent required by law, or giving truthful testimony in response to direct questions asked pursuant to a lawful subpoena or other legal process); or
(v)
at any time during the Participant’s employment with the Employer, either directly or indirectly, on the Participant’s own behalf or on behalf of any other person or entity, by or through any means, serves as an officer, board member, board advisor, stockholder, owner, employee, partner, proprietor, investor, joint venture partner, affiliate, agent, representative or consultant of any other person, corporation, firm,

- 9 -

 

 


partnership or other entity whatsoever that competes directly or indirectly with the Employer anywhere in the world, in any line of business engaged in (or reasonably planned to be engaged in) by the Employer; provided, however, that the Participant may hold, as a passive investment, up to (i) 2% of any class of securities of any private enterprise (but without active participation in the activities of such enterprise); or (ii) 1% of any class of securities of any publicly-traded enterprise (but without active participation in the activities of such enterprise).

Each Participant represents, warrants, agrees, and understands that: (i) the covenants and agreements set forth in this Section 8 are reasonable in their geographic scope, temporal duration, and the type and scope of activities they restrict; (ii) the Employer’s agreement to employ a Participant, and a portion of the compensation to be paid to a Participant hereunder, are in consideration for such covenants and such Participant’s continued compliance therewith, and constitute adequate and sufficient consideration for such covenants; (iii) each Participant shall not raise any issue of, nor contest or dispute, the reasonableness of the geographic scope, temporal duration, or content of such covenants and agreements in any proceeding to enforce such covenants and agreements; (iv) the enforcement of any remedy hereunder will not prevent any Participant from earning a livelihood, because each Participant’s past work history and abilities are such that each Participant can reasonably expect to find work in other areas and lines of business; (v) the covenants and agreements set forth in this Section 8 are essential for the Employer’s reasonable protection, are designed to protect the Employer’s legitimate business interests, and are necessary and implemented for legitimate business reasons; and (vi) in entering into these agreements, the Employer has relied upon each Participant’s representation that such Participant will comply in full with the covenants and agreements set forth in this Section 8.

 

9.
Golden Parachute

Anything in this Plan to the contrary notwithstanding, if any payment or benefit a Participant would receive from the Employer or otherwise (“Payment”) would (i) constitute a “parachute payment” within the meaning of Section 280G of the Code; and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment shall be equal to the Reduced Amount. The “Reduced Amount shall be either (x) the largest portion of the Payment that would result in no portion of the Payment being subject to the Excise Tax; or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in Executive’s receipt, on an after-tax basis, of the greater amount of the Payment. Any reduction made pursuant to this Section 9 shall be made in accordance with the following order of priority: (i) stock options whose exercise price exceeds the fair market value of the optioned stock (“Underwater Options”), (ii) Full Credit Payments (as defined below) that are payable in cash, (iii) non-cash Full Credit Payments that are taxable, (iv) non-cash Full Credit Payments that are not taxable, (v) Partial Credit Payments (as defined below) and (vi) non-cash employee welfare benefits. In each case, reductions shall be made in reverse chronological order such that the payment or benefit owed on the latest date following the occurrence of the event triggering the excise tax will be the first payment or benefit to be reduced (with reductions made pro-rata in the event payments or benefits are owed at the same time). “Full Credit Payment” means a payment, distribution or benefit, whether paid or payable or distributed or distributable pursuant to the terms of this Plan or otherwise, that if reduced in value by one dollar reduces the amount of the parachute payment (as defined in Section 280G of the Code) by one dollar, determined as if such payment, distribution or benefit had been paid or distributed

- 10 -

 

 


on the date of the event triggering the excise tax. “Partial Credit Payment” means any payment, distribution or benefit that is not a Full Credit Payment.

A nationally recognized certified public accounting firm selected by the Company (the “Accounting Firm”) shall perform the foregoing calculations related to the Excise Tax. If a reduction is required pursuant to this Section 9, the Accounting Firm shall administer the ordering of the reduction as set forth in this Section 9. The Employer shall bear all expenses with respect to the determinations by such accounting firm required to be made hereunder. Any good faith determinations of the Accounting Firm made hereunder shall be final, binding, and conclusive upon each Participant and the Employer.

10.
Plan Administrator.

The Plan is administered by the Company (the “Plan Administrator”). The Plan Administrator is the named fiduciary under the Plan. In exercising fiduciary responsibilities, the Plan Administrator will have discretionary authority (a) to determine whether and to what extent Participants and beneficiaries are entitled to Plan benefits, and (b) to construe the Plan terms. The Plan Administrator will be deemed to have properly exercised such discretionary authority unless the Plan Administrator has abused its discretion hereunder by acting arbitrarily and capriciously.

Inquiries to the Plan Administrator should be addressed to the Plan Administrator, BioAtla, Inc, c/o Senior Vice President, Human Resources, 11085 Torreyana Road, San Diego, California 92121, telephone number (858) 558-0708.

11.
Plan Sponsor.

The sponsor of this Plan is BioAtla, Inc. The Plan Sponsor’s employer identification number assigned by the Internal Revenue Service is 85-1922320. The Plan Number is 0503.

12.
Plan Year.

Each Plan Year is January 1 to December 31, provided that the first plan year shall be September 15, 2022 to December 31, 2022.

13.
Type of Plan.

This is an employee welfare plan, which provides separation pay benefits to eligible Participants. The Plan is an unfunded plan administered by the Plan Administrator. When separation pay benefits are payable under the terms of this Plan, the benefits are paid from the general assets of the Plan Sponsor. All Plan benefits are paid by the Plan Sponsor and no Participant contributions are required.

14.
Legal Service.

Any legal notices regarding this Plan should be sent to the Plan Administrator, BioAtla, Inc. c/o Senior Vice President, Human Resources, 11085 Torreyana Road, San Diego, California 92121.

- 11 -

 

 


15.
Claims Procedure.

If a Participant disagrees with a response to a claim for benefits under this separation pay plan, the Participant may make a claim to the Plan Administrator. This claim should be in the form of a letter stating why the Participant disagrees and should include all facts and information the Participant wants the Plan Administrator to consider. The Participant will be advised of the acceptance or rejection of his or her claim within 90 days after the claim is received, unless special circumstances require an extension of time for processing the claim. If the Plan Administrator requires an extension, written notice of the extension will be furnished to the Participant prior to the end of the initial 90-day period. The extension will not exceed an additional period of 90 days. The extension notice from the Plan Administrator will state the special circumstances requiring the extension of time and the date by which the Plan Administrator expects to make a final decision.

In the event the Participant’s claim is wholly or partially denied, it must be denied in writing or by electronic notice and the denial must state in detail the specific reasons for the denial, the specific plan provisions upon which the denial is based, any additional material or information which the Participant may provide which would entitle him or her to the benefits claimed, an explanation of why such material or information is necessary, and an explanation of the Plan’s review procedures and the time limits applicable to such procedures, including a statement of the Participant’s right to bring a civil action under Section 502(a) of ERISA following a denial on review of the claim. Any electronic notice will comply with the regulations of the U.S. Department of Labor.

If the Participant chooses to submit a claim for review by the Plan Administrator, then within 60 days after the date the claim is denied, the Participant or his or her authorized representative must make a written request to the Plan Administrator for review. The Participant’s request for review of a denied claim should include a statement of the reasons the claim should be allowed, all facts in support of the request and any other matters the Participant or his or her authorized representative feels are pertinent. The Participant or his or her representative shall be provided, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to his or her claim, and the Participant may also submit additional written comments, documents, records, and other information to the Plan Administrator which support the Participant’s claim.

The Plan Administrator will advise the Participant of the decision in writing within 60 days following receipt of the Participant’s request for review, unless special circumstances require an extension of time for processing (not to exceed an additional 60 days). If an extension is necessary, a decision will be made as soon as possible, but not later than 120 days after the Plan Administrator receives the Participant’s request for review. If an extension of time for review is required because of special circumstances, written notice of the extension, the Plan Administrator’s reasons for needing more time, and the date by which the Plan Administrator expects to render its decision on the review will be furnished to the Participant prior to the commencement of the extension. The decision on review will be in writing or by electronic notice and will include specific reasons for the decision, specific references to the plan provisions upon which the decision is based, a statement that the Participant is entitled to receive, upon request and free of charge, reasonable access to and copies of all documents and other information relevant to the Participant’s claim on appeal, and a statement of the Participant’s rights to bring suit under Section 502(a) of ERISA following the denial of an appeal. Any electronic notice will comply with the regulations of the U.S. Department of Labor.

- 12 -

 

 


If the Participant’s claim is denied on appeal, the Participant has a right to bring an action under Section 502(a) of the Employee Retirement Income Security Act of 1974, as amended. The Participant must pursue all claims and appeals procedures described in this Plan document before the Participant seeks any other legal recourse with respect to Plan benefits.

The Plan Administrator will establish rules and procedures, consistent with the Plan and with ERISA, as necessary and appropriate in carrying out its responsibilities in reviewing benefit claims. The Plan Administrator may require a Participant who wishes to submit additional information in connection with an appeal from the denial of benefits to do so at the Participant’s own expense. The Plan Administrator shall have sole and exclusive discretion over claims and appeals issues and determinations, regardless of the timing of such determination or the exercise of such discretion.

No legal action for benefits under the Plan may be brought until the Participant (i) has submitted a written application for benefits in accordance with the procedures described above, (ii) has been notified by the Plan Administrator that the application is denied, (iii) has filed a written request for a review of the application in accordance with the appeal procedure described above, and (iv) has been notified that the Plan Administrator has denied the appeal. Notwithstanding the foregoing, if the Plan Administrator does not respond to the Participant’s claim or appeal within the relevant time limits specified above, the Participant may bring legal action for benefits under the Plan pursuant to Section 502(a) of ERISA.

16.
ERISA Rights.

As a participant in this Plan you are entitled to certain rights and protections under the Employee Retirement Income Security Act of 1974 (ERISA). ERISA provides that all plan participants shall be entitled to:

Receive Information about Your Plan and Benefits

Examine, without charge, at the Plan Administrator’s office and at other specified locations, such as worksites and union halls, all documents governing the plan, including insurance contracts and collective bargaining agreements, and a copy of the latest annual report (Form 5500 Series) filed by the Plan with the U.S. Department of Labor and available at the Public Disclosure Room of the Employees Benefits Security Administration.

Obtain, upon written request to the Plan Administrator, copies of documents governing the operation of the Plan, including insurance contracts and collective bargaining agreements, and copies of the latest annual report (Form 5500 Series) and updated summary plan description. The Plan Administrator may make a reasonable charge for the copies.

Receive a summary of the Plan’s annual financial report, if applicable. The Plan Administrator is required by law to furnish each Participant with a copy of this summary annual report.

Prudent Actions by Plan Fiduciaries

In addition to creating rights for plan participants ERISA imposes duties upon the people who are responsible for the operation of the employee benefit plan. The people who operate your plan, called “fiduciaries” of the plan, have a duty to do so prudently and in the interest of you and other plan participants and beneficiaries. No one, including your employer, your union, or any other person, may

- 13 -

 

 


fire you or otherwise discriminate against you in any way to prevent you from obtaining a welfare benefit or exercising your rights under ERISA.

Enforce Your Rights

If your claim for a welfare benefit is denied or ignored, in whole or in part, you have a right to know why this was done, to obtain copies of documents relating to the decision without charge, and to appeal any denial, all within certain time schedules.

Under ERISA, there are steps you can take to enforce the above rights. For instance, if you request a copy of plan documents or the latest annual report from the plan and do not receive them within 30 days, you may file suit in a Federal court. In such a case, the court may require the Plan Administrator to provide the materials and pay you up to $110 a day until you receive the materials, unless the materials were not sent because of reasons beyond the control of the administrator. If you have a claim for benefits which is denied or ignored, in whole or in part, you may file suit in a state or Federal court. In addition, if you disagree with the plan’s decision or lack thereof concerning the qualified status of a domestic relations order or a medical child support order, you may file suit in Federal court. If it should happen that plan fiduciaries misuse the plan’s money, or if you are discriminated against for asserting your rights, you may seek assistance from the U.S. Department of Labor, or you may file suit in a Federal court. The court will decide who should pay court costs and legal fees. If you are successful the court may order the person you have sued to pay these costs and fees. If you lose, the court may order you to pay these costs and fees, for example, if it finds your claim is frivolous.

Assistance with Your Questions

If you have any questions about your plan, you should contact the Plan Administrator. If you have any questions about this statement or about your rights under ERISA, or if you need assistance in obtaining documents from the Plan Administrator, you should contact the nearest office of the Employee Benefits Security Administration, U.S. Department of Labor, listed in your telephone directory or the Division of Technical Assistance and Inquiries, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue N.W., Washington, D.C., 20210. You may also contact the Employee Benefits Security Administration by calling 1-866-444-EBSA, or viewing the web-site at http://www.dol.gov.ebsa.

17.
Right to Amend or Terminate Plan.

The Company reserves the right to amend or terminate this Plan without the consent of Participants, except that, during a Potential Change of Control Period and on and after a Change of Control, the Plan may only be amended or terminated with the written consent of a majority of the then covered Participants. Notwithstanding the foregoing, once an eligible Participant has incurred a CIC Qualifying Termination, as applicable, the Plan may not be amended or terminated with respect to such Participant without such Participant’s written consent.

18.
No Guarantee of Employment.

This Plan is not a guarantee of continued employment. A Participant’s employment remains terminable by either the Participant or the Employer with or without cause.

- 14 -

 

 


IN WITNESS WHEREOF, the Company has caused this Separation Pay Plan to be executed this 21st day of September, 2022.

BIOATLA, INC.

By: /s/ Jay M. Short, Ph.D.
Name: Jay M. Short, Ph.D.

Title: Chief Executive Officer

 

 

- 15 -

 

 


EXHIBIT A

Eligible Position

CIC Severance Multiple

CIC Severance Period

Senior Vice President and Above

1.0

12 months

Vice President

0.75

9 months

 

 

- 16 -

 

 


EXHIBIT B

BIOATLA, INC.
 

[Date]

[Name]

Re: Participation in BioAtla, Inc. Management Change of Control Severance Plan

Dear [Name]:

The purpose of this letter is to inform you that you have been designated by BioAtla, Inc. (the “Company” and together with its U.S. subsidiaries and/or affiliates, the “Employer”), as a participant in the Company’s Management Change of Control Severance Plan, a copy of which is enclosed herewith (as in effect from time to time, the “Plan”). Capitalized terms used in this letter but not otherwise defined herein have the meanings given to those terms in the Plan.

Subject to the terms and conditions of the Plan, if you undergo a CIC Qualifying Termination and, in each case, satisfy the Conditions, the Employer will provide you the applicable severance benefits described in the Plan.

Your participation in the Plan is governed in all respects by the terms and conditions of the Plan (including, without limitation, your restrictive covenant obligations set forth in Section 8 of the Plan), and in the event of any conflict between this letter and the Plan, the Plan will control.

Sincerely,


BioAtla, Inc.

_________________________________
Name:

Title:

I acknowledge and agree that my participation in the Plan is governed in all respects by the terms and conditions of the Plan (including, without limitation, my restrictive covenant obligations set forth in Section 8 of the Plan).

_________________________________
[Name]

_________________________________ (Date)

- 17 -

 

 


EX-101.SCH 3 bcab-20220915.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 bcab-20220915_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Securities Act File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications EX-101.PRE 5 bcab-20220915_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document And Entity Information
Sep. 15, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 15, 2022
Entity Registrant Name BioAtla, Inc.
Entity Central Index Key 0001826892
Entity Emerging Growth Company false
Securities Act File Number 001-39787
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 85-1922320
Entity Address, Address Line One 11085 Torreyana Road
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92121
City Area Code 858
Local Phone Number 558-0708
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol BCAB
Security Exchange Name NASDAQ
XML 7 bcab-20220915_htm.xml IDEA: XBRL DOCUMENT 0001826892 2022-09-15 2022-09-15 false 0001826892 BioAtla, Inc. 8-K 2022-09-15 DE 001-39787 85-1922320 11085 Torreyana Road San Diego CA 92121 858 558-0708 false false false false Common Stock, $0.0001 par value per share BCAB NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName - bcab-20220915.htm 8 bcab-20220915.htm bcab-20220915.xsd bcab-20220915_lab.xml bcab-20220915_pre.xml bcab-ex10_1.htm http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "bcab-20220915.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "bcab-20220915.htm" ] }, "labelLink": { "local": [ "bcab-20220915_lab.xml" ] }, "presentationLink": { "local": [ "bcab-20220915_pre.xml" ] }, "schema": { "local": [ "bcab-20220915.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "bcab", "nsuri": "http://www.bioatla.com/20220915", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "bcab-20220915.htm", "contextRef": "C_c6349fce-1c31-4b2a-a751-36006b9ed653", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document And Entity Information", "role": "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "bcab-20220915.htm", "contextRef": "C_c6349fce-1c31-4b2a-a751-36006b9ed653", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Securities Act File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.bioatla.com/20220915/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0000950170-22-018700-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-22-018700-xbrl.zip M4$L#!!0 ( &I(-55TG0(RP!8 L 0 1 8F-A8BTR,#(R,#DQ-2YH M=&WM7>M7XSBR_SY_A2YS=PZ9J\V]%;V@YB M29A2GMR\VSGNGIR?[_S]Z/"_,$:G'\XOT 6[0\=AP6_9*<_#.,T'@J'=[N<] M=)[$/&'H]_=7G]!I&@[Z+"D01KVBR#KM]MW=78M&/,G3>%# 4'DK3/MMA''9 M]XE@1%Y&IZ1@J&-HAH$U'QOZM>9U++VCFRW3-K7_T;2.IHV?2K.AX#>] NV& M>T@^!",G"8OC(?K $Y*$G,2H6P^Y#W,,6^@XCM&5?"I'5RQGXI;1ENSRI\-> M ;0 >B3YNYV)>=^9K53V Y*/F]W/MI]Y/WJV;\ON' M^M7E-"2_);OKYDF:7 #;!0\7/T8+T2Z&&6M#0YR4+<=#%8L?&@_3+@1)\B@5 M?24J-C41R3*^2(" 3GU]N^?/W7#'NL3 M/,L'RF9$H1X:;K2E<-8-@Y $4_T'/"5%3)1*R(::K]L[1S^APQXC%/Y$AP4O M8G;DX5\/V^5?Y<4^*XC2+\S^'/#;=SLG:5* UN%K(/(."LM?[W8*=E^T2[EM MRU[;5;>'04J'JB?*;U%>#&/V;H?R/(O)4#*3'>P<'?+[CFS.1/E73BE+U%_' MW$:G>[[C4PW[S RPY5(7$U=GF-JN:SF>Y=H6S"HA?3D*XYUC0 @J M4>)#3&ZJZ=X75RR"%_DC=$S+CT*&]=#4L148!#JS=6PZH%N!SZACFSM'$8ES M=MB>FLWBR=%(HTP':;&9X6'+ M4';_*QL^;Y(:B(UG.)YO/&FF'K-TT_5];(?0GT4="WNZ[V$W\/3 MEFD>\'\ M3*_8#<^E8!<7<.=Y$WW/TV,0PQ(FY^;:GF:_8!$3L%*P_.A08D8G5UH! R*% M(1VIZ>]VUG+?N_4O^M!VE.DJ>DX(EQ[0I_;H/9*_;-:^8-4 MP!UT@@N%PSO]B M'1U^9\5!GX@;GJB>R@L2?7&/R747KNAP13T3D3Z/AYUKWF>Y,BZNTCY)ZL># MM"C2?M6#&I3$_";IQ"PJ)#CE&4GJN=_U>,$P7 E9)Q,,WPF2S<]K4(8F(E9 @4D_'HCTD%"X47B5'0F>*KM'3?+LZOSTY1]_KX^JQ[& A8O;IG)[]=G5^?GW71\<4I.OO]Y!_' M%Q_/T,GEY\_GW>[YY479KN+/J[^_LS]F #0QL&0_X6H=!*%UJP*:[.+J[1U=F7RZOK MAR3[=6GM;"FMOPQ$/@ W%14IZK)0!?UT$Z4"Z?8NW4-IA(H>D[<&@A<K652-H14?X,-FYU."" MEAVU"S';8RT6,SU6R8* M'I*X$C'H91'V/:0!M5 \&%^HVHWN=QXRH9\WN 2,J,NS UDP/AV9H88LP M Q-/\S"-;-\U#)V$@;MY+_L0W]^?7QY??SK> M1^<7)ZT13$W_L8PPF-OCP[BM625?@NZ[9_<$S&.Y@)9V0[T=A$B.NAD+Y08% M13Q!YT6.3GH$S :Q]T)._+SSTRP7S7+QW?192Z_.;]FN/N76S3:YG&YZ!+=]FV(H" MAKW ";#MAY0XS DCW5G6M2H3!LZ3,!7@/:HRGXVW],Z93&Y Y?Q._RK)BJS#@IB!\3W"-&Q9H0:MBSX&]%M$_N1 M:[G$=DS"C-4HR <>,Q@;O/%-%W9-@W?U7<]MI'W#I#T(O,#471_KFNEBR]- MT.I M(VTP&FUH<*_A]"OA'B%>Z+NNA\,P\K$5N@[V?9]@QW>TD&B![5MTI;AW G^] M%-?IW<9OD79A[J>*;2DC8< MGWQ#-_1F([K967KVSE*E%3+%^XN -9UG)$9G]RP,CR[=ES_.%= MSXWD6J//3]5G6-B07-F^N1N\\$1?U C2)#"K$+T: UXS0T,C6 M \W7P$%Q?'!5; ,'KAEA&A"+:(Y+'.HNZ][("*%DTC8X-)[MO7%T<(N$SS:# M4'>\ &L1T^71!@=['B%89[YN&I%&"+.7%;Y/*6#\%PD=VY'?;=L>UESM,2EL MK*H?S:IJS*>-=7E?4D&;8@'*[?P JR83Z$)5"Q"H^ED%E_81CV2%@.2&4=25 M&T?H$\F+JA;1R]4,,&?+X#X339NB 4^B[K+UZ!:19P,MO),>"[^JDG,DRT2: M"2Z/^@3I/0I8G-Y)79 WI8H@#_^*(EB>P,WB.>*R"PHZ4J0HY_U!7)"$I8,\ M'J*<%#R/ANK)ZH$T *J5V?]5B3LQKM$!! /](\FPOA?!ZI?>R>?D[BR7ATKR MA0[=.I(4S4#$Q-<%)H46&Y8"M7KI5]9>??=>R#AXSN[?"!ZRH"SR:)"_*)@I97@W /+8, MNU+DF0*6LF[EKNZBDP]7R#"U%C0,_% M 8TB^)_MA)$1N)J[=&9,%PR $!B2W'P&A >8CQL-656JV(BTJ%_1=EX]= LP MT)C0D*FZKB/]D.5L5,M&1:8KEX>6KH5$!W%W#&SIGH.#2#.QYE$6Z83"RR^M M(E\$DVN(_.***F NS1MQ&45,-*JR(E4!$N-P@L:/KBJZ1;&Q&^P]37'*MHWJ M3*E.:/B^IT$5^%5N,?"K,^-< MKF-HVG1;ON\\5MROI6G&8VWLF1#W\[JQ9KO9B$KTLW$\8QS'V\#@^L:I:%FX MXEI^;;*L/!_V4!B3/%^[Y,)O"$H9\#5L>[_^3PZYMU;RLGYQYK5G:Z/_+Z__ MUX)(AE;?W1OV8;#=-6*'^I]1=5-7FU]K/::0*C'"8'5\:6 M^W<>7ED?&W/S1.F%DL\"WS"T@!J8.;:%K2#0L6?;&M9"AP6^%T8.7?I@5^7T M#74C4&;E%FP>I_T^J$.W2,.O^^B_H6]-TQ&XD.B6Q .&,OE!Z=X&U9E>)_EO MEL8&L[Y=U,9R3-NU?4PLAV++BB+L4Y?@***.9?BF160E^^4PJ[*"2_MW\P'K M_9Y0N??&4#!$H8[@;1FP[$9FB\"[WA4]N867R>1' MDB/*(J"Q^E!9F52EV0L^"3S^$K")=B4FN@?J=)P1':@$J_HA& Y4)9.?.I-Y MSN5^H!%@XXF?&9[K7.X1CI^?Z+ZUJRHZS-O8?U>1/RKFO0^I"(ZLO =W1 M-\!X'R!X(;+SN>SU'N VBUE8 &XGJ=J]'^1,M0*:53GRT#+G:D<_4Y]TED*E MQHJ'".8+<\A^=@-2!)*!,*21C*#Y3)QGE!$DH$S
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end